Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera.

Literature DB >> 30635625

Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera.

Jared S Fowles¹, Joan How¹, Maggie J Allen¹, Stephen T Oh².

Abstract

Entities: Disease Gene Mutation Species

Mesh：

Substances：
Biomarkers, Tumor

Year: 2019 PMID： 30635625 PMCID： PMC6759365 DOI： 10.1038/s41375-018-0349-9

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

15 in total

1. Aging is associated with circulating cytokine dysregulation.

Authors: Lorena Alvarez-Rodríguez; Marcos López-Hoyos; Pedro Muñoz-Cacho; Víctor Manuel Martínez-Taboada
Journal: Cell Immunol Date: 2012-01-12 Impact factor: 4.868

Review 2. Myeloproliferative Neoplasms: A Contemporary Review.

Authors: Ayalew Tefferi; Animesh Pardanani
Journal: JAMA Oncol Date: 2015-04 Impact factor: 31.777

3. Age-related differences in disease characteristics and clinical outcomes in polycythemia vera.

Authors: Brady L Stein; Santosh Saraf; Urszula Sobol; Anna Halpern; Jamile Shammo; Damiano Rondelli; Laura Michaelis; Olatoyosi Odenike; Alfred Rademaker; Anaadriana Zakarija; Brandon McMahon; Jerry L Spivak; Alison R Moliterno
Journal: Leuk Lymphoma Date: 2013-01-08

4. The origin and evolution of mutations in acute myeloid leukemia.

Authors: John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal: Cell Date: 2012-07-20 Impact factor: 41.582

5. Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Authors: Prajwal Boddu; Lucia Masarova; Srdan Verstovsek; Paolo Strati; Hagop Kantarjian; Jorge Cortes; Zeev Estrov; Sherry Pierce; Naveen Pemmaraju
Journal: Ann Hematol Date: 2017-11-15 Impact factor: 3.673

6. 'CHIP'ping away at clonal hematopoiesis.

Authors: D C Link; M J Walter
Journal: Leukemia Date: 2016-06-17 Impact factor: 11.528

7. Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.

Authors: Rakhee Vaidya; Naseema Gangat; Thitina Jimma; Christy M Finke; Terra L Lasho; Animesh Pardanani; Ayalew Tefferi
Journal: Am J Hematol Date: 2012-09-11 Impact factor: 10.047

8. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.

Authors: David A Hinds; Kimberly E Barnholt; Ruben A Mesa; Amy K Kiefer; Chuong B Do; Nicholas Eriksson; Joanna L Mountain; Uta Francke; Joyce Y Tung; Huong Marie Nguyen; Haiyu Zhang; Linda Gojenola; James L Zehnder; Jason Gotlib
Journal: Blood Date: 2016-06-30 Impact factor: 22.113

9. Effect of mutation order on myeloproliferative neoplasms.

Authors: Christina A Ortmann; David G Kent; Jyoti Nangalia; Yvonne Silber; David C Wedge; Jacob Grinfeld; E Joanna Baxter; Charles E Massie; Elli Papaemmanuil; Suraj Menon; Anna L Godfrey; Danai Dimitropoulou; Paola Guglielmelli; Beatriz Bellosillo; Carles Besses; Konstanze Döhner; Claire N Harrison; George S Vassiliou; Alessandro Vannucchi; Peter J Campbell; Anthony R Green
Journal: N Engl J Med Date: 2015-02-12 Impact factor: 91.245

10. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.

Authors: E K Engle; D A C Fisher; C A Miller; M D McLellan; R S Fulton; D M Moore; R K Wilson; T J Ley; S T Oh
Journal: Leukemia Date: 2014-09-25 Impact factor: 11.528

5 in total

1. Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.

Authors: Yoko Edahiro; Kohshi Ohishi; Akihiko Gotoh; Katsuto Takenaka; Hirohiko Shibayama; Takayuki Shimizu; Kensuke Usuki; Kazuya Shimoda; Masafumi Ito; Scott A VanWart; Oleh Zagrijtschuk; Albert Qin; Hiroaki Kawase; Narihisa Miyachi; Toshiaki Sato; Norio Komatsu; Keita Kirito
Journal: Int J Hematol Date: 2022-04-16 Impact factor: 2.319

2. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.

Authors: Alberto Alvarez-Larrán; Marta Garrote; Francisca Ferrer-Marín; Manuel Pérez-Encinas; M Isabel Mata-Vazquez; Beatriz Bellosillo; Eduardo Arellano-Rodrigo; Montse Gómez; Regina García; Valentín García-Gutiérrez; Mercedes Gasior; Beatriz Cuevas; Anna Angona; María Teresa Gómez-Casares; Clara M Martínez; Elena Magro; Rosa Ayala; Rafael Del Orbe-Barreto; Raúl Pérez-López; Maria Laura Fox; José-María Raya; Lucía Guerrero; Carmen García-Hernández; Gonzalo Caballero; Ilda Murillo; Blanca Xicoy; M José Ramírez; Gonzalo Carreño-Tarragona; Juan Carlos Hernández-Boluda; Arturo Pereira
Journal: Cancer Date: 2022-04-13 Impact factor: 6.921